Comparison and Assessment of Anti‐Inflammatory and Antioxidant Capacity Between <scp>EGCG</scp> and Phosphatidylcholine‐Encapsulated <scp>EGCG</scp>

Minjia Yuan, Lili Hu, Cuicui Zhu, Qi Li, Hang Tie, Haihua Ruan, Tao Wu, Hongyang Zhang, Liang XuJournal of Cosmetic Dermatology 2024 · DOI

TL;DR

This study investigates how encapsulating Epigallocatechin gallate (EGCG), a potent antioxidant from green tea, with phosphatidylcholine impacts its skin absorption, anti-inflammatory, and antioxidant properties. The findings reveal that phosphatidylcholine encapsulation significantly enhances EGCG's skin penetration and anti-inflammatory effects, while maintaining its strong antioxidant capabilities, paving the way for more effective cosmetic formulations.

What Problem Does This Paper Address?

The cosmetics industry is constantly seeking natural ingredients with enhanced efficacy. Epigallocatechin gallate (EGCG) is a well-known antioxidant and anti-inflammatory compound found in green tea, but its direct application in cosmetics is limited by poor skin absorption due to its hydrophilic nature. This hinders its ability to reach target sites within the skin and exert its beneficial effects. The paper addresses this challenge by exploring whether encapsulating EGCG with phosphatidylcholine, a key component of cell membranes, can improve its delivery and overall performance in cosmetic applications.

Methods

The researchers employed a multi-faceted approach to evaluate the efficacy of phosphatidylcholine-encapsulated EGCG (<EGCG>) compared to EGCG alone:

  • Transdermal Absorption: Porcine skin, a common model for human skin, was used in a modified Franz diffusion apparatus to measure the concentration of EGCG and <EGCG> that penetrated the skin.
  • Cytotoxicity Assay: CCK-8 assays were performed on both human keratinocytes (HaCaT) and mouse monocyte/macrophage leukemia cells (Raw264.7) to determine the safe concentration ranges for subsequent experiments.
  • Anti-inflammatory Assessment: LPS-induced Raw264.7 cells were used to model inflammation. The levels of pro-inflammatory cytokines TNF-α, COX-2, and PGE2 were measured using ELISA kits to assess the anti-inflammatory potential of EGCG and <EGCG>.
  • Antioxidant Assessment: A 3D epidermal model (EpiKutis) was used to simulate skin conditions. Reactive Oxygen Species (ROS) levels were detected using a fluorescence probe (DCFH-DA) after UVB irradiation to evaluate the antioxidant capacity of EGCG and <EGCG>.

Datasets

Not discussed in the paper. The study utilized in vitro models (porcine skin, cell lines, 3D epidermal models) and standard laboratory reagents.

Key Insights and Ideas

  • Phosphatidylcholine as a Delivery Vehicle: The study highlights phosphatidylcholine's potential as an effective encapsulating agent for improving the delivery of hydrophilic cosmetic ingredients like EGCG. By mimicking cell membrane structures, it enhances lipophilicity and cell membrane affinity.
  • Enhanced Skin Penetration: The encapsulation strategy significantly boosted EGCG's penetration into the skin, suggesting a more efficient delivery mechanism for topical applications.
  • Synergistic Anti-inflammatory Action: The combination of EGCG with phosphatidylcholine not only improved its absorption but also amplified its ability to suppress key inflammatory markers, offering a more potent anti-inflammatory effect than EGCG alone.
  • Maintained Antioxidant Power: While the encapsulation improved absorption and anti-inflammatory effects, the antioxidant capacity of <EGCG> remained comparable to that of EGCG, indicating that the core beneficial properties are preserved.

Key Results

  • Skin Absorption: The concentration of <EGCG> in porcine skin was significantly higher (40.76±1.29 µg/cm²) compared to EGCG alone (31.62±2.01 µg/cm²), indicating a ~28.91% increase in skin absorption.
  • Anti-inflammatory Efficacy: At a concentration of 4 µg/mL, <EGCG> reduced TNF-α secretion by 78.84%, compared to 62.48% for EGCG alone. Similar superior inhibition was observed for COX-2 and PGE2.
  • Antioxidant Capacity: Both EGCG and <EGCG> demonstrated significant ROS scavenging ability. The relative IOD values for ROS reduction were comparable between the two groups, with <EGCG> showing a slight, non-significant advantage.
  • Cytotoxicity: Both EGCG and <EGCG> showed comparable cytotoxicity profiles, with cell viability remaining above 80% at concentrations up to 20 µg/mL, suggesting a good safety margin for cosmetic applications.

Limitations and Future Work

  • In Vitro Limitations: The authors acknowledge that all experiments were conducted in vitro. Future work should involve in vivo studies to validate these findings in a more complex biological system and confirm the practical efficacy and safety of <EGCG> in cosmetic products.
  • Broader Efficacy Exploration: While this study focused on anti-inflammatory and antioxidant properties, the authors suggest that future research should investigate other potential cosmetic benefits of <EGCG>, such as whitening, anti-wrinkle, soothing, and antisensitivity effects.
  • Mechanism of Action: Further investigation into the precise mechanisms by which phosphatidylcholine enhances EGCG's effects, beyond improved absorption, could provide deeper insights.

Summary updated

Abstract

The percutaneous absorption and anti-inflammatory impact of EGCG encapsulated within phosphatidylcholine were substantially enhanced when compared to EGCG by itself. Additionally, both formulations exhibited enhanced ROS scavenging capacities, albeit the variance between them was not pronounced. These insights furnish a vital theoretical underpinning for the utilization of phosphatidylcholine-encapsulated EGCG in cosmetic applications, specifically for fostering products with anti-inflammatory and antioxidant benefits.
BibTeX
@article{yuan2024comparison,
  author = {Minjia Yuan and Lili Hu and Cuicui Zhu and Qi Li and Hang Tie and Haihua Ruan and Tao Wu and Hongyang Zhang and Liang Xu},
  title = {{Comparison and Assessment of Anti‐Inflammatory and Antioxidant Capacity Between <scp>EGCG</scp> and Phosphatidylcholine‐Encapsulated <scp>EGCG</scp>}},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.16628},
}
Figure